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Abstract--A clinically applicable method for assessing the permeability of the alveolar- 
capillary barrier under non-steady-state conditions has been developed. Following de- 
position of a suitable tracer in the lungs, its rate of entry into the blood can be measured 
using blood samples alone, without the necessity for external monitoring. A second 
reference tracer must be infused in order to compensate for renal excretion and for 
redistribution of tracer in the extravascular space. Tracers of any convenient molecular 
weight and physical properties can be used, either unlabelled, or labelled with stable 
or radioactive isotopes. 
The method was examined by computer simulation in order to assess its sensitivity 
to measurement "'noise". In contrast o other non-steady-state tracer techniques, it is 
markedly less sensitive to experimental uncertainty, and measurements to an accuracy 
of 1-2% (coefficient of variation) should suffice for most purposes. The method was 
also validated by in vivo experiment in the pig, using a constant intravenous infusion 
of S~Cr-EDTA as the reference tracer and a variable intravenous infusion of 99mTc-DTPA 
to simulate ntry from the alveoli. Good agreement was obtained between the calculated 
entry rate of the 99mTc-DTPA and the true entry rate known from the infusion pump 
rate. 
INTRODUCTION 
Alterations in the function of the alveolar-capil lary barrier can occur in a wide range of 
clinical circumstances. However,  a major problem in establishing the link between a 
potentially damaging stimulus and the consequent pulmonary response is the lack of an 
objective technique for measuring the function of this barrier[l]. One approach as been 
to measure its permeabil ity to the labelled chelate 99mTc-DTPA using external scintillation 
detection. This technique provides an easily derived index of barrier permeability, but is 
confined to tracers with a narrow range of molecular weights. The problem is exacerbated 
by the need to make measurements in an out-of-steady-state system, when flux rates and 
pool sizes are changing, since existing methods for studying alveolar permeability depend 
on steady-state or quasi-steady-state conditions[2-5]. We have circumvented these dit: 
ficulties by employing a non-steady-state racer technique to measure the rate of entry 
of a suitable tracer into the systemic circulation and have validated our method both 
theoretically, by computer simulation, and practically, by in vivo experiment in the pig. 
METHODS 
Principle 
Given a tracer which has been deposited in the alveoli, for instance by inhalation of 
an aerosol, the problem is to measure the rate at which such a tracer appears in the 
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circulation after crossing the alveolar-capillary barrier. The problem is trivial if the tracer 
remains in the blood pool and is neither excreted nor metabolised. In practice however, 
tracers which are convenient to use do not accumulate in the blood in this way and it is 
therefore necessary to make corrections for their distribution in extra-vascular pools and 
for their excretion. We have chosen to employ 5tCr-labelled EDTA as our tracer. This is 
an inert chelate which is distributed in the extra-cellular space and excreted by glomerular 
filtration[6] and the short-term kinetics of this substance are well modelled by a two- 
compartment system as shown in Fig. 1. 
In such a compartmental system, the rate at which material (tracee or tracer) flows 
out of any compartment, Ra, is proportional to the quantity of material q present here: 
Razc q (1) 
or  
Ra = kq, (2) 
where k is a constant of proportionality, commonly referred to as a rate constant. In the 
system under discussion, the rate of change of the quantity of tracer in the sampled 
compartment (the blood) is simply the difference between the rate of inflow and outflow 
of tracer: 
dqt 
= R,, + kzlqz - Ra - k lzql ,  (3) 
dt 
where q~ and q_, are the quantities of tracer in the sampled and peripheral compartments 
respectively, R , and Ra are  the rates of appearance and disappearance of tracer from the 
sampled compartment, and the ks are rate constants (see Fig. 1). 
Similarly, the rate at which the quantity of tracer in the peripheral, inaccessible com- 
partment (i.e. the extra-vascular, extra-cellular fluid) changes is: 
dq_, 
dt = k12ql - k21q2. (4) 
The solution to this first-order, linear differential equation is[7]: 
fo q2 = qz(O) exp(-k,_lt) + kl2 exp( -kz l t )  exp(k, . iT)ql(T)  dT, (5) 
t l  2k2 2 I 
Fig. 1. Two-compartment model of EDTA kinetics, kt-_ and k.,~ represent the fractional exchange coefficients 
between compartment 1 (which includes plasma and is therefore accessible for sampling) and 2 Iwhich is not 
accessible). Rd is the rate of irreversible loss of material from the system. 
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SO that if rate constants k,_- and k_,~ are known, for instance by prior measurement, Eq. 
(5) allows the quantity of tracer present in the inaccessible compartment a any time to 
be deduced from tracer measurements in the sampled compartment alone. In practice it 
is more convenient to measure tracer concentration c. than mass. so that it is also nec- 
essary to know the volume V~ of distribution of the sampled compartment: 
q, = ViOl. (6) 
A convenient way to establish both the volume of distribution and the rate constants for 
exchange is to measure the tracer concentrations following a spike injection of tracer into 
the blood under steady-state conditions[7]. 
Given the quantity of tracer in the inaccessible compartment. Eq. (3) then allows com- 
putation of the rate of irreversible loss of tracer, Ra, from which the instantaneous renal 
clearance u can be derived: 
R,I Vi 
u(t) = (7) 
ql 
If a second tracer with the same kinetics but a different label now enters the blood 
from the lungs, Eq. (5) can be used to deduce the quantity of tracer in the peripheral 
compartment from measurements in the blood. Given the instantaneous renal clearance 
calculated with Eq. (7), Eq. (3) can then be solved for the unknown rate of entry of the 
second tracer from the lungs (see Table 1). 
Computer simulation 
A 4 hr experiment was simulated, in which 100 units of the test tracer were deposited 
in the lungs of an adult human at time zero and absorbed into the blood with a half-life 
of 60 min for the first 2 hr, changing to a half-life of 20 rain for the following 2 hr. These 
values correspond to the half-lives observed in nonsmokers and in cigarette smokers, who 
have much more permeable lungs[l]. The tracer kinetics typified those of 5~Cr-EDTA in 
a normal adult[8], with exchange rate constants kt,_. and kz~ of 0.042 and 0.126/min, re- 
spectively (Fig. 2). The glomerular filtration rate of the tracer was assumed to be 120 ml/ 
rain initially, changing to 150 ml/min at 2 hr, both GFR and alveolar permeability altering 
simultaneously in order to test the analysis under the most rigorous conditions. A reference 
tracer with the same kinetics but a different label was assumed to have been infused into 
the blood at a constant rate of 100 U/rain. The blood concentrations of the two tracers 
which would have been observed under these circumstances were then calculated at 10 
Table 1. Calculation of the unknown rate of entry of the pulmonary tracer into the circulation under non- 
steady-state conditions 
1. Carry out a preliminary steady-state experiment tomeasure rate constants k~: and kz~ and the sampled 
volume of distribution V~. 
2. Using the observed blood concentrations of the infused reference tracer, c~, during the non-steady-state 
experiment, calculate the corresponding quantity of tracer in the sampled compartment, q~. using Eq. (6). 
3. Calculate the quantity of the reference tracer in the inaccessible compartment, qz using Eq. (5). 
4. Calculate the rate of disappearance of the reference tracer, Ra, using Eq. (3) and hence the time-varying 
rate constant km using Eq. (2). 
5. Using the observed blood concentrations of the pulmonary test racer during the non-steady-state 
experiment, calculate the corresponding quantity of tracer in the sampled compartment using Eq. (6). 
6. Calculate the quantity of the test racer in the inaccessible compartment using Eq. (5). 
7. Calculate the unknown rate of entry of the test racer into the sampled compartment using Eq. (3). 
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Fig. 2. Three-compartment system simulating pulmonary absorption of tracer in an adult man. k,., and k:, 
represent first-order rate constants as for Fig. 1. Compartment 3 represents he lung content of the pulmonary 
test tracer. R~ is the rate at which the reference tracer is infused into the accessible compartment. Rdis the rate 
of irreversible oss of material from the system. 
min intervals (for details, see [9]). Given these simulated observations, the rate of entry 
of the pulmonary tracer was then calculated as described in Table 1. 
To investigate the effects of measurement uncertainty on the results, random noise of 
various magnitudes likely in practice was then added to the simulated observations de- 
scribed above, and the unknown rate of entry of the pulmonary tracer recalculated. 
In vivo validation 
A crossbred piglet weighing 8.5 kg was anaesthetised with Ketamine (10 mg/kg IM) 
and Diazepam (2 mg/kg IM), followed by 0.5% Methoxyflurane and 50:50 N,_O and 02. 
Catheters were placed in the jugular vein for infusion of tracers, and in the carotid artery 
for blood sampling and pressure measurement. Throughout he experiment body tem- 
perature, arterial blood pressure, heart rate. respiratory rate, blood gases and ECG were 
monitored. 
An initial steady-state experiment was carried out to measure the rate constants for 
exchange and the sampled volume of distribution in which approximately 10 ixCi (370 
kBq) 5~Cr-EDTA (Amersham International) was injected intravenously and 14 samples 
of arterial blood withdrawn during the succeeding 2 hr. 5'Cr-EDTA was then infused as 
the reference tracer at a rate of approximately 40 txCi/hr (1.5 MBq/hr) and arterial blood 
sampled at 5 min intervals for the next 2 hr. To simulate a varying rate of transfer of 
tracer from lung to blood 99mTc-DTPA (Byk-Mallinckrodt) was infused from a second 
pump at three different rates varying between I0/aCi/hr (370 kBq/hr) and 50 ~xCi/hr (1.85 
MBq/hr). 
Radioactivity was measured in an LKB Wallac GTL 300-1000 with a 7.5 x 7.5 cm 
diameter sodium iodide crystal. Approximately 10 a counts were collected to ensure that 
the relative standard deviation of the measured tracer concentrations was less than 2% 
after correcting for background activity. 
Program MLP[10] was used to fit two-exponential functions to the 5'Cr-EDTA con- 
centrations during the initial steady-state experiment. The rate constants for the exchange 
between the compartments, k 2 and k._,. were then calculated by standard methods[7]. 
Smooth curves were fitted through the rest of the data using weighted least-squares po- 
lynomial splines[11], the curves being smoothed until the residual mean-square error was 
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of similar magnitude to the known measurement uncertainty of each datum. The curves 
and their first derivatives were interpolated at appropriate points and Eq. (5) was solved 
by numerical integration[ 12]. 
Computer simulation 
The curves of simulated blood tracer concentration are shown in Fig. 3 for the infused 
reference tracer and for the pulmonary test tracer. The calculated rate of entry of the 
pulmonary tracer using these data is shown in Fig. 4, on both linear and logarithmic scales. 
Using values at 10 rain intervals for the two 120 rain periods of the simulation gave halt- 
lives of 60.0 and t9.5 min, respectively, for the tracer in the lung. 
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Fig. 3. Blood tracer concentrations forthe computer simulation described in the text: (a) concentration f the 
infused reference tracer; (b) concentration f the pulmonary test racer. 
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Fig. 4. Calculated rate of  entry into the blood of  the pulmonary tracer for the computer simulation, based on 
the data of  Fig..3: (a) entry rate on a linear scale: (b) entry rate on a logarithmic scale. 
In vivo validation 
The effect of adding random noise of 1.5% coefficient of variation to the perfect data 
of Fig. 3 is shown in Fig. 5. The entry rates based on these input data are shown in Fig. 
6, and correspond to half-lives of 58.3 and 23.2 rain for the two periods of the simulation. 
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The observed curves of blood tracer concentration for the two tracers are shown in 
Fig. 7. The calculated rate of entry into blood of the 99mTc-DTPA is shown in Fig. 8, 
together with the known infusion rate. The average entry rates for the 99mTc-DTPA were 
calculated using values at 5 rain intervals for the periods 0-60, 60-90 and 90-115 min. 
The averages were 452,239 and 1230 kcpm/min, respectively, in comparison with the true 
rates of 430, 213 and 1060 kcpm/min. 
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Fig. 5. Blood tracer concentrations for the computer simulation of Fig. 3 after the addition of 1.5% random 
noise: (a) concentration of the infused reference tracer: (b) concentration of the pulmonary tracer. 
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Fig. 6. Calculated rate of entry into blood of the pulmonary tracer for the computer simulation, based on the 
noise-contaminated ata of Fig. 5: (a) entry rate on a linear scale: (b) entry rate on a logarithmic scale.  
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Fig. 7. Observed curves of blood tracer concentration for the in vivo validation experiment described in the 
text: (a) concentration of ~Cr-EDTA (the infused reference tracer): (b) concentration of 99mTc-DTPA. 
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Fig. 8. Calculated rate of entry into blood of 99mTc-DTPA (solid line) based on the data of Fig. 7. together with 
the knmvn entry rate (broken line). 
DISCUSSION 
This paper reports a new technique for measuring lung permeability in non-steady-state 
conditions. It has been validated by a computer simulation designed to model the case 
of a normal adult whose lungs suddenly became highly permeable and also by in vivo 
experiment in a normal/low/high permeability situation with instantaneous changes be- 
tween states. In both cases the technique performed well. However, rigorous validation 
in vivo requires an independent method of measuring the rate of entry into blood of the 
tracer deposited in the lungs. At first sight, the most promising approach is the direct 
measurement of the quantity of tracer in the lungs but it is difficult to make accurate 
measurements of radioactivity in an anisotropic structure by external detection, without 
recourse to a technique such as positron emission tomography. To circumvent his prob- 
lem, delivery of tracer from the lungs was simulated by direct injection into the systemic 
circulation using an infusion pump, thus removing any possible uncertainty about the rate 
at which the tracer was entering the circulation and also enabling it to be changed at will. 
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Using this method we found good agreement between the known and calculated rate of 
entry' of the tracer. 
Comparison of the results using noise-free data from a computer simulation with those 
using data corrupted by the addition of random noise indicates that the analysis is less 
sensitive to measurement uncertainty than other two-compartment techniques which have 
been investigated[9, 13]. Our results indicate that tracer measurements to an accuracy of 
between 1 and 2% at a sampling frequency of 6/hr should suffice for clinical measurements 
of lung permeability in non-steady-state conditions. 
For reasons of convenience, we have employed radioactive tracers for the present 
work. However, a major advantage of our method, which requires blood samples alone 
and not external detection, is that any convenient label can be used on the tracer. Thus 
for example, a stable isotope might be employed, measurable by mass spectrometry, or 
even a chemical tracer, which can be measured in a gas chromatograph. An additional 
advantage of this approach is that it then becomes possible to make simultaneous mea- 
surements of the passage of tracers of a range of molecular sizes. 
In conclusion, a clinically applicable method for the assessment of lung permeability 
has been developed which offers several advantages over existing techniques. The method 
is amenable to accurate validation and should provide a reference technique for com- 
parison with alternative methods such as external detection. 
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